3-V Biosciences' Series C - II Round

3-V Biosciences raised a round of funding on June 23, 2013.

3-V Biosciences is a clinical-stage pharmaceutical company developing therapeutics in metabolic diseases, focusing on non-alcoholic steatohepatitis, and oncology.…

Articles about 3-V Biosciences' Series C - II Round: